Profile data is unavailable for this security.
About the company
Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. The Company supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One systems reduces patients' reliance on stationary concentrators and oxygen compressed gas tanks. Its Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5 and Rove 6 consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers. It also offers Simeox, which is an airway clearance device.
- Revenue in USD (TTM)326.65m
- Net income in USD-92.44m
- Incorporated2001
- Employees834.00
- LocationInogen Inc859 WARD DRIVEGOLETA 93111United StatesUSA
- Phone+1 (805) 562-0500
- Fax+1 (302) 636-5454
- Websitehttps://www.inogen.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sight Sciences Inc | 79.40m | -52.32m | 212.80m | 214.00 | -- | 2.09 | -- | 2.68 | -1.06 | -1.06 | 1.61 | 2.03 | 0.474 | 1.53 | 4.18 | 371,004.70 | -31.24 | -38.78 | -34.01 | -42.20 | 85.80 | 80.74 | -65.90 | -105.14 | 10.50 | -26.50 | 0.2494 | -- | 13.63 | 60.84 | 35.59 | -- | 6.77 | -- |
| Electromed Inc | 54.72m | 5.15m | 214.24m | 174.00 | 44.02 | 4.94 | 35.76 | 3.92 | 0.5791 | 0.5791 | 6.17 | 5.16 | 1.12 | 3.27 | 2.25 | 314,459.80 | 10.51 | 8.64 | 12.51 | 10.09 | 76.26 | 76.26 | 9.41 | 8.06 | 5.27 | -- | 0.00 | 0.00 | 13.83 | 11.82 | 62.67 | 21.06 | -22.23 | -- |
| Accuray Inc | 444.20m | -20.08m | 216.21m | 987.00 | -- | 4.77 | -- | 0.4868 | -0.2032 | -0.2032 | 4.48 | 0.4503 | 0.9353 | 2.01 | 5.25 | 450,054.70 | -4.23 | -1.37 | -7.35 | -2.33 | 31.09 | 36.43 | -4.52 | -1.55 | 0.8655 | -0.0936 | 0.7901 | -- | -0.2355 | 1.29 | -67.51 | -- | -3.54 | -- |
| Neuropace Inc | 71.82m | -29.90m | 219.27m | 171.00 | -- | 22.14 | -- | 3.05 | -1.09 | -1.09 | 2.61 | 0.3392 | 0.7305 | 1.74 | 6.49 | 419,994.20 | -30.41 | -- | -34.66 | -- | 74.15 | -- | -41.63 | -- | 5.47 | -4.37 | 0.8565 | -- | 43.72 | -- | 30.00 | -- | -- | -- |
| Orchestra Biomed Holdings Inc | 2.08m | -55.58m | 233.76m | 56.00 | -- | 5.02 | -- | 112.44 | -1.57 | -1.57 | 0.0586 | 1.23 | 0.021 | 1.34 | 16.57 | 37,125.00 | -56.06 | -- | -64.66 | -- | 92.02 | -- | -2,673.26 | -- | 4.58 | -- | 0.00 | -- | -21.88 | -- | -37.91 | -- | -- | -- |
| Utah Medical Products, Inc. | 46.58m | 15.63m | 236.13m | 169.00 | 15.68 | 1.92 | 11.94 | 5.07 | 4.33 | 4.33 | 12.92 | 35.45 | 0.3576 | 1.99 | 12.81 | 275,609.50 | 12.00 | 12.69 | 12.43 | 13.19 | 58.99 | 61.57 | 33.56 | 30.51 | 23.68 | -- | 0.00 | 37.05 | -3.93 | 3.64 | 0.9834 | 1.65 | 9.71 | 1.86 |
| LifeMD Inc | 178.28m | -26.60m | 251.95m | 207.00 | -- | -- | -- | 1.41 | -0.7004 | -0.7004 | 4.70 | -0.101 | 3.59 | 6.86 | 38.19 | 861,255.40 | -44.31 | -153.05 | -333.96 | -526.91 | 88.92 | 83.66 | -12.34 | -45.44 | 0.8327 | -8.19 | 1.13 | -- | 28.15 | 78.90 | 51.27 | -- | 143.64 | -- |
| Anika Therapeutics Inc | 164.17m | -97.52m | 252.78m | 357.00 | -- | 1.41 | -- | 1.54 | -6.64 | -6.64 | 11.14 | 12.24 | 0.5868 | 1.47 | 5.21 | 459,854.30 | -34.86 | -5.41 | -38.55 | -5.87 | 62.70 | 60.70 | -59.40 | -12.60 | 3.78 | -- | 0.00 | -- | 6.67 | 9.56 | -456.34 | -- | 3.11 | -- |
| Atlantic International Corp | 205.26m | -62.29m | 255.75m | 7.00 | -- | 9.77 | -- | 1.25 | -8.72 | -8.72 | 14.59 | 0.5222 | 2.91 | -- | 7.03 | 29,322,780.00 | -88.44 | -71.97 | -174.30 | -106.09 | 10.70 | 61.01 | -30.35 | -1,471.82 | -- | -1.33 | 0.7735 | -- | -100.00 | -- | -37.43 | -- | -- | -- |
| Inogen Inc | 326.65m | -92.44m | 263.04m | 834.00 | -- | 1.40 | -- | 0.8053 | -3.97 | -3.97 | 13.97 | 7.91 | 0.9562 | 6.85 | 7.49 | 391,670.30 | -27.06 | -8.23 | -33.51 | -9.53 | 42.56 | 44.54 | -28.30 | -10.31 | 2.37 | -- | 0.00 | -- | -16.32 | -2.49 | -22.30 | -- | 26.34 | -- |
| Jin Medical International Ltd | 20.13m | 2.91m | 286.48m | 245.00 | 98.18 | 10.92 | 94.00 | 14.23 | 0.0186 | 0.0186 | 0.1292 | 0.1676 | 0.5576 | 2.38 | 4.22 | 82,143.59 | 7.80 | 12.81 | 11.27 | 20.92 | 34.73 | 33.58 | 13.99 | 14.60 | 2.27 | -- | 0.2702 | 0.00 | 3.29 | -1.07 | 6.34 | -4.80 | -9.50 | -- |
| Zynex Inc | 193.67m | 4.82m | 286.93m | 1.10k | 60.84 | 8.15 | 30.68 | 1.48 | 0.1481 | 0.1481 | 5.91 | 1.11 | 1.40 | 2.57 | 7.05 | 176,059.10 | 3.48 | 14.58 | 4.06 | 17.52 | 80.20 | 79.62 | 2.49 | 10.44 | 3.15 | 4.15 | 0.6246 | -- | 16.54 | 42.01 | -42.91 | 0.3741 | 2.19 | -- |
| Semler Scientific Inc | 58.94m | 15.91m | 289.49m | 92.00 | 19.44 | 3.32 | 17.49 | 4.91 | 2.05 | 2.05 | 7.58 | 11.99 | 0.6868 | 17.20 | 9.33 | 640,619.60 | 18.54 | 38.83 | 20.37 | 44.41 | 88.05 | 90.22 | 27.00 | 32.58 | 3.09 | -- | 0.00 | -- | 20.28 | 25.98 | 43.69 | 32.64 | -0.3821 | -- |
| AngioDynamics, Inc. | 292.73m | -243.03m | 292.57m | 748.00 | -- | 1.50 | -- | 0.9995 | -6.04 | -6.04 | 7.25 | 4.79 | 0.7434 | 2.27 | 6.55 | 391,344.90 | -61.72 | -16.38 | -74.39 | -18.70 | 51.71 | 52.95 | -83.02 | -30.49 | 1.41 | -- | 0.00 | -- | -10.28 | 2.35 | -251.53 | -- | 13.09 | -- |
| Pulmonx Corp | 79.30m | -57.11m | 293.79m | 279.00 | -- | 3.13 | -- | 3.70 | -1.47 | -1.47 | 2.04 | 2.38 | 0.45 | 1.24 | 7.29 | 284,236.60 | -32.41 | -26.27 | -36.42 | -28.97 | 74.16 | 71.95 | -72.01 | -93.76 | 6.77 | -- | 0.2839 | -- | 27.98 | 27.98 | -3.26 | -- | 20.62 | -- |
| Delcath Systems Inc | 11.88m | -56.33m | 309.69m | 76.00 | -- | 73.69 | -- | 26.07 | -2.55 | -2.55 | 0.505 | 0.1501 | 0.4322 | 0.6198 | 6.17 | 156,289.50 | -204.97 | -116.57 | -356.98 | -243.21 | 77.05 | 71.02 | -474.22 | -1,235.37 | 2.04 | -54.37 | 0.5172 | -- | -24.05 | -9.53 | -30.60 | -- | -5.26 | -- |
Data as of Nov 11 2024. Currency figures normalised to Inogen Inc's reporting currency: US Dollar USD
53.32%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Divisadero Street Capital Management LPas of 30 Jun 2024 | 2.35m | 9.89% |
| Camber Capital Management LPas of 30 Jun 2024 | 2.00m | 8.43% |
| Brown Capital Management LLCas of 30 Jun 2024 | 1.95m | 8.23% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 1.48m | 6.25% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 1.42m | 5.98% |
| Columbia Management Investment Advisers LLCas of 30 Jun 2024 | 831.29k | 3.51% |
| JPMorgan Investment Management, Inc.as of 30 Sep 2024 | 751.23k | 3.17% |
| Weatherbie Capital LLCas of 30 Jun 2024 | 696.63k | 2.94% |
| Bridgeway Capital Management LLCas of 30 Jun 2024 | 599.21k | 2.53% |
| AQR Capital Management LLCas of 30 Jun 2024 | 570.99k | 2.41% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
